Quantcast

Latest kidney diseases Stories

2014-07-28 20:24:33

HAYWARD, Calif., July 28, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the second quarter ended June 30, 2014. Net loss for the three months ended June 30, 2014 was $7.3 million, compared to $8.3 million for the same period in 2013. The decrease in net loss is a direct result of a decrease in interest expense in the current period. Net loss for the six months ended June 30, 2014 was $15.2 million,...

2014-07-17 16:26:45

NEW YORK, July 17, 2014 /PRNewswire/ -- La Jolla Pharmaceutical Company (NASDAQ: LJPC) is a biopharmaceutical company focused on the development of therapeutic agents that inhibit the activity of galectins as a means of treating human diseases such as chronic organ failure and cancer. The company's main product candidates include GCS-100 for the treatment of chronic kidney disease (CKD), LJPC-501 that is designed to help restore kidney function in patients with hepatorenal syndrome...

Hot Days May Increase Odds Of Developing Kidney Stones
2014-07-11 09:27:32

Rebekah Eliason for redOrbit.com – Your Universe Online According to a new study, as daily temperatures rise, more patients seek treatment for kidney stones. The research team discovered among several US cities with varying climates there is a correlation between hot days and kidney stones in 60,000 people. "We found that as daily temperatures rise, there is a rapid increase in the probability of patients presenting over the next 20 days with kidney stones," said study leader Gregory...

2014-07-10 12:28:45

Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval of Vifor Fresenius Medical Care Renal Pharma's new phosphate binder Velphoro, which was approved by the FDA in November 2013 for the treatment of...

2014-07-10 08:27:57

The Family Reunion Health Guide helps families talk about the connection between diabetes, high blood pressure, and kidney disease WASHINGTON, July 10, 2014 /PRNewswire-USNewswire/ -- The National Kidney Disease Education Program (NKDEP) offers the Family Reunion Health Guide to help African American families talk at family reunions and other summer events about the connection between kidney disease, and more common conditions like diabetes and high blood pressure. Designed to be used by...

2014-07-10 04:21:24

STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical candidate Nefecon(R) issued in the key markets United States, Europe, China and Hong Kong. A patent is pending in Japan. Nefecon is a potential disease-modifying treatment for patients with primary IgA nephropathy at risk of developing end-stage renal disease. Nefecon has shown positive results in an...

2014-07-10 00:20:46

--CHOP-Led Research Finds Link between Hotter Days, Kidney Stones in U.S. Adults and Children-- PHILADELPHIA, July 10, 2014 /PRNewswire/ -- As daily temperatures increase, so does the number of patients seeking treatment for kidney stones. In a study that may both reflect and foretell a warming planet's impact on human health, a research team found a link between hot days and kidney stones in 60,000 patients in several U.S. cities with varying climates. "We found that as daily...

2014-07-09 08:27:28

World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named Martin Schreiber, M.D., as its new vice president of clinical affairs for home modalities. http://photos.prnewswire.com/prnvar/20140303/LA75036LOGO-b DaVita's home hemodialysis (HHD) and peritoneal dialysis (PD)...

2014-07-03 11:16:59

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH study suggests people with either should be monitored for both Acute kidney injury (AKI) and chronic kidney disease (CKD) are closely intertwined, with each disease a risk factor for developing the other and sharing other risk factors in common, as well as sharing causes for the diseases to get worse, and outcomes, suggests a comprehensive analysis by scientists at the National Institutes of Health and George...

2014-06-30 16:26:14

NEW YORK, June 30, 2014 /PRNewswire/ -- According to the National Kidney Foundation, chronic kidney disease affects over 26 million adults in the U.S., and is caused by diabetes and high blood pressure. As kidney functions deteriorate, the kidney's ability to produce red blood cells declines, and results in anemia. Anemia is a condition in which the patient's blood is deficient in red blood cells and hemoglobin. Kidney dialysis is expensive, and the cost of anemia drugs has been...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related